Cited by 433Neurotransmitter Receptor Influence on BehaviorNeuropeptides and Animal PhysiologyNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.

Understanding opioid reward

Open access

Fields, Howard L., Margolis, Elyssa B.·2015·Trends in Neurosciences

DOI 10.1016/j.tins.2015.01.002PMC PMC4385443

Open this paper in CoChat — free account

Abstract

Opioids are the most potent analgesics in clinical use; however, their powerful rewarding properties can lead to addiction. The scientific challenge is to retain analgesic potency while limiting the development of tolerance, dependence, and addiction. Both rewarding and analgesic actions of opioids depend upon actions at the mu opioid (MOP) receptor. Systemic opioid reward requires MOP receptor function in the midbrain ventral tegmental area (VTA) which contains dopaminergic neurons. VTA dopaminergic neurons are implicated in various aspects of reward including reward prediction error, working memory, and incentive salience. It is now clear that subsets of VTA neurons have different pharmacological properties and participate in separate circuits. The degree to which MOP receptor agonists act on different VTA circuits depends upon the behavioral state of the animal, which can be altered by manipulations such as food deprivation or prior exposure to MOP receptor agonists.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.tins.2015.01.002

Cites

131 of 131 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS.
Dahlstroem, A., & Fuxé, K. (1964) · PubMed · Cited by 5,133
Stereotaxic mapping of the monoamine pathways in the rat brain
Ungerstedt, U. (1971) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.1971.tb10998.x · Cited by 3,819
Dopamine in motivational control: rewarding, aversive, and alerting
Bromberg-Martin, E. S., Matsumoto, M., & Hikosaka, O. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.022 · Cited by 2,396
Dopamine neuron systems in the brain: An update
Björklund, A., & Dunnett, S. B. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.006 · Cited by 1,777
The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat
Swanson, L. W. (1982) · Brain Research Bulletin · doi:10.1016/0361-9230(82)90145-9 · Cited by 1,718
Opioids excite dopamine neurons by hyperpolarization of local interneurons
Johnson, S., & North, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00483.1992 · Cited by 1,637
The mysterious motivational functions of mesolimbic dopamine
Salamone, J. D., & Correa, M. (2012) · Neuron · doi:10.1016/j.neuron.2012.10.021 · Cited by 1,418
REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade
Tzschentke, T. M. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00070.x · Cited by 1,336
Neuron-type-specific signals for reward and punishment in the ventral tegmental area
Cohen, J. Y., Haesler, S., Vong, L., Lowell, B. B., & Uchida, N. (2012) · Nature · doi:10.1038/nature10754 · Cited by 1,318
Input-specific control of reward and aversion in the ventral tegmental area
Lammel, S., Lim, B. K., Ran, C., Huang, K. W., Betley, M. J., Tye, K. M., Deisseroth, K., & Malenka, R. C. (2012) · Nature · doi:10.1038/nature11527 · Cited by 1,300

Show all 131 references

Sorted by citations

Items 201–300 of 433

Exploring the association between melatonin and nicotine dependence (Review)
Georgakopoulou, V., Sklapani, P., Τράκας, Ν., Reiter, R. J., & Spandidos, D. A. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5406 · Cited by 12
Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit
Adewumi, A. D., Staatz, C. E., Hollingworth, S., Connor, J. P., & Alati, R. (2018) · Drug Safety · doi:10.1007/s40264-018-0687-6 · Cited by 11
Novel Positive Allosteric Modulators of µ Opioid Receptor—Insight from In Silico and In Vivo Studies
Bartuzi, D., Kędzierska, E., Kaczor, A. A., Schmidhammer, H., & Matosiuk, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228463 · Cited by 11
Aquaporin-4 deletion attenuates opioid-induced addictive behaviours associated with dopamine levels in nucleus accumbens
Lv, Y., Jing, M., Li, P.-Y., Zhao, T.-Y., Pang, C., Lu, G.-Y., Wang, Z., Wu, N., Hu, G., Song, R., et al. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.108986 · Cited by 11
Conditioned Reward of Opioids, but not Psychostimulants, is Impaired in GABA‐A Receptor δ Subunit Knockout Mice
Siivonen, M. S., de Miguel, E., Aaltio, J., Manner, A. K., Vahermo, M., Yli‐Kauhaluoma, J. T., Linden, A.-M., Aitta‐aho, T., & Korpi, E. R. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13043 · Cited by 11
Naloxone disrupts the development of a conditioned ejaculatory preference based on a somatosensory cue in male rats.
Quintana, G. R., Cautela, B. V. G., Borduas, E., Lemay, V., Villanueva, F. Y., & Pfaus, J. G. (2019) · Behavioral Neuroscience · doi:10.1037/bne0000302 · Cited by 11
Differential disruption of conditioned ejaculatory preference in the male rat based on different sensory modalities by micro-infusions of naloxone to the medial preoptic area or ventral tegmental area
Quintana, G. R., Birrel, M., Marceau, S., Kalantari, N., Bowden, J., Bachoura, Y., Borduas, E., Lemay, V., Payne, J. W., Cionnaith, C. E. M., et al. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05334-9 · Cited by 11
GluA1 in Central Amygdala Promotes Opioid Use and Reverses Inhibitory Effect of Pain
Hou, Y.-Y., Cai, Y.-Q., & Pan, Z. Z. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.11.032 · Cited by 11
Reward Enhances Pain Discrimination in Humans
Becker, S., Löffler, M., & Seymour, B. (2020) · Psychological Science · doi:10.1177/0956797620939588 · Cited by 12
Preoperative Predictors of Prolonged Opioid Use in the 6 Months After Total Knee Arthroplasty
Larach, D. B., Kertai, M. D., Billings, F. T., Anderson, S. B., Polkowski, G. G., Shinar, A. A., Milne, G. L., Mishra, P., & Bruehl, S. P. (2023) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000001143 · Cited by 10
The therapeutic potential of low-intensity focused ultrasound for treating substance use disorder
Olaitan, G. O., Lynch, W. J., & Venton, B. J. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1466506 · Cited by 11
Preclinical Assessment of the Analgesic Pharmacology of NKTR-181 in Rodents
Kopruszinski, C. M., Swiokla, J., Lee, Y. S., Navratilova, E., VanderVeen, L. A., Yang, M., Liu, Y., Miyazaki, T., Schmidt, W. K., Zalevsky, J., et al. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00816-3 · Cited by 10
Dorsal Raphe Nucleus Serotoninergic Neurons Mediate Morphine Rewarding Effect and Conditioned Place Preference
Fu, B., Yao, J.-Q., Lu, C., Wang, B., Li, Z., Huang, M., Tian, T., Peng, H., & Liu, S. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.10.031 · Cited by 10
Neurotensin and Alcohol Use Disorders: Towards a Pharmacological Treatment
Rodriguez, F. D., Sánchez, M. L., & Coveñas, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108656 · Cited by 10
A Nonrewarding NMDA Receptor Antagonist Impairs the Acquisition, Consolidation, and Expression of Morphine Conditioned Place Preference in Mice
Tomazi, L., Mello, C. F., Schöffer, A. P., Girardi, B., Frühauf, P. K. S., & Rubin, M. A. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9678-0 · Cited by 10
Blockade of the Dopamine D3 Receptor Attenuates Opioids-Induced Addictive Behaviours Associated with Inhibiting the Mesolimbic Dopamine System
Hu, R., Yang, M., Ding, X., Wu, N., Li, J., & Song, R. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01059-0 · Cited by 9
Changes in peripheral endocannabinoid levels in substance use disorders: a review of clinical evidence
Elliott, G., Petrie, G. N., Kroll, S. L., Roche, D. J. O., & Mayo, L. M. (2025) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2025.2456499 · Cited by 9
Enriched environment and social isolation differentially modulate addiction-related behaviors in male offspring of morphine-addicted dams: The possible role of μ-opioid receptors and ΔFosB in the brain reward pathway
Yazdanfar, N., Farnam, A., Sadigh‐Eteghad, S., Mahmoudi, J., & Sarkaki, A. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.02.005 · Cited by 9
Neuroimaging of opioid effects in humans across conditions of acute administration, chronic pain therapy, and opioid use disorder
Martucci, K. T. (2024) · Trends in Neurosciences · doi:10.1016/j.tins.2024.04.005 · Cited by 10
Qualitative and quantitative analysis of opiate and related metabolites in human urine samples by UPLC-MS/MS
Jin, Y., Zhao, J., Xu, X., & Wang, Y. (2021) · International Journal of Mass Spectrometry · doi:10.1016/j.ijms.2021.116575 · Cited by 9
Potential therapeutic targets for the treatment of opioid abuse and pain
Kiguchi, N., & Ko, M. (2022) · Advances in pharmacology · doi:10.1016/bs.apha.2021.09.002 · Cited by 9
A common SNP in Chrna5 enhances morphine reward in female mice
Brynildsen, J. K., Yang, K., Lemchi, C. O., Dani, J. A., Biasi, M. D., & Blendy, J. A. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109218 · Cited by 10
Mu opioid receptor stimulation in the medial preoptic area or nucleus accumbens facilitates song and reward in flocking European starlings
Polzin, B. J., Maksimoski, A. N., Stevenson, S. A., Zhao, C.-J., & Riters, L. V. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.970920 · Cited by 9
Norepinephrine in the Medial Pre-frontal Cortex Supports Accumbens Shell Responses to a Novel Palatable Food in Food-Restricted Mice Only
Latagliata, E. C., Puglisi‐Allegra, S., Ventura, R., & Cabib, S. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00007 · Cited by 9
Presynaptic Mu Opioid Receptors Suppress the Functional Connectivity of Ventral Tegmental Area Dopaminergic Neurons with Aversion-Related Brain Regions
Wu, Y., Perez‐Rosello, T., Awatramani, R. B., & Surmeier, D. J. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.1194-24.2025 · Cited by 9
Episodic Ethanol Exposure in Adolescent Rats Causes Residual Alterations in Endogenous Opioid Peptides
Granholm, L., Segerström, L., & Nylander, I. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00425 · Cited by 8
M3 but not M4 muscarinic receptors in the rostromedial tegmental nucleus are involved in the acquisition of morphine-induced conditioned place preference
Wu, J., Li, X., Zhou, P., & Li, X. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173274 · Cited by 8
Pain, negative affective states and opioid-based analgesics: Safer pain therapies to dampen addiction
Massaly, N., Markovic, T., Creed, M. C., Al‐Hasani, R., Cahill, C. M., & Morón, J. A. (2021) · International review of neurobiology · doi:10.1016/bs.irn.2020.09.002 · Cited by 12
The effect of intraperitoneal and intra-RMTg infusions of CTAP on rats’ social interaction
Li, X., Wu, J., Li, X., & Zhang, J. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114333 · Cited by 6
Interactive Mechanisms of Supraspinal Sites of Opioid Analgesic Action: A Festschrift to Dr. Gavril W. Pasternak
Rossi, G. C., & Bodnar, R. J. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00961-9 · Cited by 8
Behavioral and Accumbal Responses During an Affective Go/No-Go Task Predict Adherence to Injectable Naltrexone Treatment in Opioid Use Disorder
Shi, Z., Jagannathan, K., Wang, A.-L., Fairchild, V. P., Lynch, K. G., Suh, J. J., Childress, A. R., & Langleben, D. D. (2019) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz002 · Cited by 8
Buprenorphine's Effect on the Human Immune System and Inflammation
Shin, S. D., Branning, R., McGinnis, M. T., Shin, A. N., Ho, M., Karpyak, V. M., & Oesterle, T. (2025) · Clinical and Translational Science · doi:10.1111/cts.70180 · Cited by 7
Associations Between Environmental Resources and the “Wanting” and “Liking” of Male Song in Female Songbirds
Spool, J. A., & Riters, L. V. (2017) · Integrative and Comparative Biology · doi:10.1093/icb/icx117 · Cited by 7
Loss of mu and delta opioid receptors on neurons expressing dopamine receptor D1 has no effect on reward sensitivity
Harda, Z., Spyrka, J., Jastrzębska, K., Szumiec, Ł., Bryksa, A., Klimczak, M., Polaszek, M., Gołda, S., Zajdel, J., Misiołek, K., et al. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108307 · Cited by 6
Therapies in early development for the treatment of opiate addiction
Rodríguez‐Arias, M., Aguilar, M. A., & Miñarro, J. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1086746 · Cited by 7
κ Opioid Receptor 1 Single Nucleotide Polymorphisms were Associated with the Methadone Dosage
Zhang, Q. Y., Shi, M., Tang, H., Zhong, H., & Lu, X. (2020) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2019.0159 · Cited by 7
μ Opioid Antagonist Naltrexone Partially Abolishes the Antidepressant Placebo Effect and Reduces Orbitofrontal Cortex Encoding of Reinforcement
Peciña, M., Chen, J., Lyew, T., Karp, J. F., & Dombrovski, A. Y. (2021) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2021.02.009 · Cited by 7
Recruitment of specific dopamine neuron sub-circuits by opioids
Morison, S. L., Doster, L. B., Vigotsky, A. D., Centeno, M. V., del Rey, N. L., Apkarian, A. V., & Awatramani, R. B. (2025) · Addiction Neuroscience · doi:10.1016/j.addicn.2025.100233 · Cited by 8
Unveiling Dopamine and Met-Enkephalin Dynamics: Simultaneous Co-Detection in Rat Striatum
Berger, J. M., Todorov, J., Turner, K. M., McCarty, G. S., Romanova, E. V., Sweedler, J. V., & Sombers, L. A. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c03599 · Cited by 6
Can the incentive-sensitization theory of addiction incorporate addiction to opioid drugs?
Robinson, T. E., & Berridge, K. C. (2026) · Psychopharmacology · doi:10.1007/s00213-025-07001-8 · Cited by 6
Upregulation of reward mesolimbic activity and immune response to vaccination: a randomized controlled trial
Lubianiker, N., Koren, T., Djerassi, M., Sirotkin, M., Singer, N., Jalon, I., Lerner, A., Sar-El, R., Sharon, H., Shahar, M., et al. (2026) · Nature Medicine · doi:10.1038/s41591-025-04140-5 · Cited by 11
Enhanced pharmacokinetic and pharmacodynamic effects of combining p-fluorofentanyl and fentanyl
Canfield, J. R., Fry, K., & Sprague, J. E. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.112710 · Cited by 6
The Development of a Macromolecular Analgesic for Arthritic Pain
Weber, L. P., Wang, X., Ren, R., Wei, X., Zhao, G., Yang, J., Yuan, H., Pang, H., Wang, H., & Wang, D. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01197 · Cited by 6
Can Src protein tyrosine kinase inhibitors be combined with opioid analgesics? Src and opioid-induced tolerance, hyperalgesia and addiction
Li, Y., Bao, Y., Zheng, H., Qin, Y., & Hua, B. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111653 · Cited by 6
Effect of human mesenchymal stem cell secretome administration on morphine self-administration and relapse in two animal models of opioid dependence
Quintanilla, M. E., Quezada, M., Morales, P., Berríos‐Cárcamo, P., Santapau, D., Ezquer, M., Herrera‐Marschitz, M., Israel, Y., & Ezquer, F. E. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02225-0 · Cited by 8
Projection-specific dopamine neurons in the ventral tegmental area participated in morphine-induced hyperalgesia and anti-nociceptive tolerance in male mice
Sun, G., Song, Z., Peng, X., Chen, P., Song, Y., Qin, X., Hua, R., & Zhang, Y. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881120985183 · Cited by 6
Preoperative brain μ-opioid receptor availability predicts weight development following bariatric surgery in women
Karlsson, H. K., Tuominen, L. J., Helin, S., Salminen, P. T. P., Nuutila, P., & Nummenmaa, L. (2021) · JCI Insight · doi:10.1172/jci.insight.147820 · Cited by 6
BNT12, a novel hybrid peptide of opioid and neurotensin pharmacophores, produces potent central antinociception with limited side effects
Wang, S., Zhang, Y.-Z., Liu, X.-H., Guo, X., Wang, X., Wang, J.-R., Liu, B., Han, F., Zhang, Y., & Wang, C. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176775 · Cited by 5
Reduced GIRK expression in midbrain dopamine neurons during prolonged abstinence from fentanyl self-administration
Pachenari, N., Channell, A. L., Belilos, A. J., Dienel, S. J., & Moussawi, K. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06747-5 · Cited by 5
The administration of the opioid buprenorphine decreases motivational error signals
Pfabigan, D. M., Rütgen, M., Kroll, S. L., Riečanský, I., & Lamm, C. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105199 · Cited by 5
Restoring the neuroprotective capacity of glial cells under opioid addiction
Spencer, A. C., Surnar, B., Kolishetti, N., Toborek, M. J., & Dhar, S. (2022) · Addiction Neuroscience · doi:10.1016/j.addicn.2022.100027 · Cited by 5
Opioid receptor antagonism and neural response to monetary rewards: Pilot studies in light and heavy alcohol users
Gowin, J. L., Sloan, M. E., Kirk‐Provencher, K. T., Rosenblatt, S. L., Penner, A. E., Stangl, B. L., Byrd, N. D., Swan, J. E., & Ramchandani, V. A. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231191707 · Cited by 5
The Neurochemical Basis of Motivation for Affiliative Touch
Løseth, G. E., Leknes, S., & Ellingsen, D. (2016) · Springer eBooks · doi:10.1007/978-1-4939-6418-5_15 · Cited by 5
Involvement of GABAA receptors of lateral habenula in the acquisition and expression phases of morphine-induced place preference in male rats
Amohashemi, E., Reisi, P., & Alaei, H. (2022) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000695 · Cited by 5
G protein‐coupled receptor modulation of striatal dopamine transmission: Implications for psychoactive drug effects
Littlepage‐Saunders, M., Hochstein, M. J., Chang, D. S., & Johnson, K. A. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16151 · Cited by 5
Chapter 47. Attention-Deficit/Hyperactivity Disorder
Wilens, T. E., & Kaminski, T. A. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615373970.kb47 · Cited by 5
Nucleus accumbens sub-regions experience distinct dopamine release responses following acute and chronic morphine exposurePreprint
Gooding, S. W., Lewis, E., Chau, C., Sandhu, S., Glienke, J., & Whistler, J. L. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.28.601282 · Cited by 6
Aberrant type 2 dopamine and mu-opioid receptor availability in autism spectrum disorder
Noppari, T., Tuisku, J., Lukkarinen, L., Tani, P., Lindberg, N., Saure, E., Lauerma, H., Tiihonen, J., Hirvonen, J., Helin, S., et al. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07620-5 · Cited by 7
VTA µ-Opioidergic Neurons Facilitate Low Sociability in Protracted Opioid Abstinence
Jo, A. Y., Xie, Y., Wooldridge, L. M., Rogers, S. A., Kimmey, B. A., Rodrigues, A., Ortega, R. A. S., Creasy, K. T., Beier, K. T., Blendy, J. A., et al. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.1154-24.2025 · Cited by 9
Blunted anterior midcingulate response to reward in opioid users is normalized by prefrontal transcranial magnetic stimulation
Biernacki, K., Goldstein, R. Z., Güth, M. R., Alia‐Klein, N., Cole, S. L., Ray, S., & Baker, T. E. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03569-z · Cited by 4
Sculptor and Destroyer
Mattson, M. P. (2023) · The MIT Press eBooks · doi:10.7551/mitpress/14422.001.0001 · Cited by 4
NOSH-aspirin (NBS-1120) attenuates motor defects and dopaminergic neuron degeneration in a rat model of Parkinson's disease
Firouzan, B., Ghasemi, R., Tetteh, M. T., Matson, J. B., & Kashfi, K. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177733 · Cited by 4
RETIRADA DE OPIOIDES: UMA REVISÃO BIBLIOGRÁFICA / OPIOID WITHDRAWAL: A LITERATURE REVIEW
de Melo, A. P., Fujii, Y. W. H., Rangel, M. P., & Nishida, F. S. (2020) · Brazilian Journal of Development · doi:10.34117/bjdv6n9-227 · Cited by 4
Role of the Extracellular Matrix in Addiction
Beloate, L. N., & Kalivas, P. W. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812202-0.00017-8 · Cited by 4
Characterizing non-heroin opioid overdoses using electronic health records
Averitt, A., Slovis, B., Tariq, A. A., Vawdrey, D., & Perotte, A. J. (2019) · JAMIA Open · doi:10.1093/jamiaopen/ooz063 · Cited by 3
The Brain, Explained: A Comprehensive Theory of Brain FunctionPreprint
Rappoport, A. (2018) · Preprints.org · doi:10.20944/preprints201805.0137.v1 · Cited by 4
Paternal morphine exposure enhances morphine self-administration and induces region-specific neural adaptations in reward-related brain regions of male offspringPreprint
Toussaint, A. B., Ellis, A. S., Bongiovanni, A. R., Peterson, D. R., Bavley, C. C., Karbalaei, R., Mayberry, H. L., Bhakta, S., Dressler, C. C., Imperio, C. G., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.03.522600 · Cited by 4
VTA μ–opioidergic neurons facilitate low sociability in protracted opioid withdrawalPreprint
Jo, A. Y., Xie, Y., Rodrigues, A., Ortega, R. A. S., Creasy, K. T., Beier, K. T., Blendy, J. A., & Corder, G. F. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.08.602522 · Cited by 4
Two-pronged control of the dorsal raphe by the VTA
Kauer, J. A., & Polter, A. M. (2019) · Neuron · doi:10.1016/j.neuron.2019.01.059 · Cited by 4
Effects of PDYN 68-bpVNTR, BDNF rs6265, OPRD1 rs569356 and OPRM1 rs2075572 polymorphisms on opioid-methamphetamine co-use
Ak, M., Özer-Uzaldı, G., Yıldırım, M. A., Özkan-Kotiloğlu, S., Danışman, M., & Kaya-Akyüzlü, D. (2025) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2025.104714 · Cited by 3
Paradoxical Ventral Tegmental Area GABA Signaling Drives Enhanced Morphine Reward After Adolescent Nicotine
Wittenberg, R. E., Yun, S., Yang, K., Swanson, O. K., Wolfman, S. L., Colón, L. M., Eisch, A. J., & Dani, J. A. (2025) · Biological Psychiatry · doi:10.1016/j.biopsych.2025.05.027 · Cited by 3
Mapping cross-modal functional connectivity of major neurotransmitter systems in the human brain
Saiz-Masvidal, C., la Peña‐Arteaga, V. D., Bertolín, S., Diez, I. P., Juaneda‐Seguí, A., Martínez‐Zalacaín, I., Chavarría-Elizondo, P., Subirà, M., Menchón, J. M., Sepulcre, J., et al. (2025) · Brain Structure and Function · doi:10.1007/s00429-025-02996-4 · Cited by 4
Progress toward Multianalyte Neurochemical Detection: Techniques and Applications
Turner, K. M., Berger, J. M., & Sombers, L. A. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00286 · Cited by 3
Allosteric modulators of the δ GABAA receptor subtype demonstrate a therapeutic effect in morphine-antinociceptive tolerance and withdrawal in mice
Genaro, K., Yoshimura, R. F., Doan, B. P., Johnstone, T. B. C., Hogenkamp, D. J., & Gee, K. W. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109221 · Cited by 3
Opioid trail: Tracking contributions to opioid use disorder from host genetics to the gut microbiome
Duffy, E. P., Bachtell, R. K., & Ehringer, M. A. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105487 · Cited by 4
Predicting Extent of Opioid Use Following Cardiac Surgery: A Pilot Study
Kertai, M. D., Rayl, R., Larach, D. B., Shah, A. S., & Bruehl, S. P. (2024) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2024.11.037 · Cited by 3
Chapter 20. Neurobiology and Treatment of Sedative-, Hypnotic-, and Anxiolytic-Related Disorders
Jones, J. L., VandenBerg, A., & Malcolm, R. J. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615373970.kb20 · Cited by 3
EGR3 regulates opioid-related nociception and motivation in male rats
Mitra, S., Thomas, S. A., Martin, J. A., Williams, J. B., Woodhouse, K. L., Chandra, R., Li, J., Lobo, M. K., Sim, F. J., & Dietz, D. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06226-1 · Cited by 3
The rostromedial tegmental nucleus RMTg is not a critical site for ethanol-induced motor activation in rats
Esposito-Zapero, C., Fernández‐Rodríguez, S., Sánchez-Catalán, M. J., Zornoza, T., Sánchez-Catalán, M. J., & Granero, L. M. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06425-4 · Cited by 3
Optical Intracranial Self-Stimulation (oICSS): A New Behavioral Model for Studying Drug Reward and Aversion in Rodents
Song, R., Soler‐Cedeño, O., & Xi, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063455 · Cited by 4
Neural pathways for reward and relief promote fentanyl addiction
Heilig, M. A., & Petrella, M. (2024) · Nature · doi:10.1038/d41586-024-01361-5 · Cited by 3
Synergistic improvement effect of nicotine-ghrelin co-injection into the anterior ventral tegmental area on morphine-induced amnesia
Yadegary, A., Nazari-Serenjeh, F., & Darbandi, N. (2020) · Neuropeptides · doi:10.1016/j.npep.2020.102025 · Cited by 3
Opioid Withdrawal and Restless Legs Syndrome
Park, E. J., & Park, Y. (2020) · Chronobiology in Medicine · doi:10.33069/cim.2020.0026 · Cited by 3
Molekularne podstawy działania wybranych substancji psychoaktywnych
Bijoch, Ł., Pękała, M., & Beroun, A. (2021) · Postępy Biochemii · doi:10.18388/pb.2021_376 · Cited by 5
Chapter 10. Neurobiology of Stimulants
Sofuoglu, M., DeVito, E. E., & Kosten, T. R. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615373970.kb10 · Cited by 3
Chapter 14. Opioid Antagonist Treatment of Opioid-Related Disorders
Capata, M., & Hartwell, K. J. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615373970.kb14 · Cited by 3
Heroin use
Salani, D. A., Zdanowicz, M. M., & Joseph, L. (2016) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20160518-05 · Cited by 5
Chapter 34. Nicotine and Public Health
Cummings, K. M., Borland, R., & Braak, D. C. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615373970.kb34 · Cited by 3
An engineered nanobody inhibitor for molecular-to-circuit control of opioid receptor functionPreprint
Valbret, Z., Lamothe‐Molina, P. J., Papadogkonaki, S., Koehl, A., Arafiles, J. V. V., Tuchman, Z. S., Fisher, N. M., Radoux-Mergault, A., Canziani, A., Huang, G., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.12.698943 · Cited by 4
The actions of morphine on microglia and the underlying effects on associated adverse effects
Wu, W., Li, Q., & Yang, F. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06956-y · Cited by 2
Design and Characterization of a Dual COX-2/Ca V 2.2 Inhibitor with Potent Analgesic Activity
Qiu, J., Tao, S., Zhang, T., Miao, Z., Hu, S., Liu, W., Su, J., Hai, A., Huang, Z., Liu, J., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02649 · Cited by 2
A metabolic framework for reward: Redefining dopamine and opioids as physiological agents
Cohen, M. T., & Atzil, S. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106608 · Cited by 3
Transmodulation of Dopaminergic Signaling to Mitigate Hypodopminergia and Pharmaceutical Opioid-induced Hyperalgesia
Brewer, R., Blum, K., Bowirrat, A., Modestino, E. J., Baron, D. A., Badgaiyan, R. D., Moran, M., Boyett, B., & Gold, M. S. (2020) · Current Psychopharmacologye · doi:10.2174/2211556009999200628093231 · Cited by 2
Chapter 4. Substance Use Disorder Diagnoses in DSM-5
Hasin, D. S., & Larson, F. R. R. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615373970.kb04 · Cited by 2
Drug Abuse Prevalence Among 10th - 12th-Grade Students of Kerman, Iran in 2017 - 2018 Academic Year
Mazhari, S., Ziaaddini, H., Nakhaee, N., & Kermanian, A. (2021) · Trends in Medical Sciences · doi:10.5812/tms.115848 · Cited by 2
The neurotoxic potential of opioids including fentanyl and fentanyl analogs
Mellon, R. D. (2022) · Advances in neurotoxicology · doi:10.1016/bs.ant.2022.04.006 · Cited by 2
Reduced dopamine release in Dcc haploinsufficiency male mice abolishes the rewarding effects of cocaine but not those of morphine and ethanol
Darcq, E., Nouel, D., Hernández, G., Pokinko, M., Ash, P., Moquin, L., Gratton, A. P., Kieffer, B. L., & Flores, C. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06288-1 · Cited by 2
A small molecule ligand for the novel pain target GPR171 produces minimal reward in mice
McDermott, M., Ram, A., Mattoon, M. T., Haderlie, E. E., Raddatz, M. C., Thomason, M. K., & Bobeck, E. N. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2023.173543 · Cited by 2
A Translational Approach to Using Endocannabinoid Modulators for Targeting Opioid-Associated Memory
Karimi‐Haghighi, S., Mozafari, R., Chavoshinezhad, S., Khosrowabadi, E., Mahmoudi, M., & Haghparast, A. (2024) · Current Addiction Reports · doi:10.1007/s40429-024-00588-6 · Cited by 2
Substance Use and Addiction
Newton, K. A., & Biase, L. M. D. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_19 · Cited by 3

Authors: Fields, H. L., & Margolis, E. B.
Affiliations: University of California, San Francisco (US)
Corresponding author: Fields, Howard L.
ORCID: Fields, Howard L.
Margolis, Elyssa B.
Venue: Trends in Neurosciences
Publisher: Elsevier BV
Published: 2015-04
Volume: 38
Issue: 4
Pages: 217-225
ISSN: 0166-2236 (ISSN-L)
DOI: 10.1016/j.tins.2015.01.002
PMC: PMC4385443
OpenAlex: W2035419353
Cited by: 432
References: 131
Citations by year: 2026: 23 · 2025: 33 · 2024: 22 · 2023: 36 · 2022: 37 · 2021: 93 · 2020: 43 · 2019: 50 · 2018: 31 · 2017: 26 · 2016: 23 · 2015: 15
FWCI: 3.77
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Trends in Neurosciences (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: National Institute on Drug Abuse (R01DA029776)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: opioid reward, mu-opioid receptor, ventral tegmental area, dopaminergic neurons, opioid use disorder, analgesia, reward prediction error, incentive salience, working memory, behavioral state, food deprivation, opioid tolerance
MeSH terms: Analgesics, Opioid, Animals, Humans, Receptors, Opioid, Reinforcement, Psychology, Reward, Receptors, Opioid, mu, Ventral Tegmental Area, Dopaminergic Neurons

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Understanding opioid reward

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks